Medicine Description recormon 5000i
Recormon 5000i PREFILLED SYRINGE is a medication that contains recombinant human erythropoietin, a glycoprotein hormone that plays a pivotal role in erythropoiesis, the process of red blood cell production. It is synthesized using recombinant DNA technology, allowing for the production of erythropoietin that is structurally identical to the naturally occurring hormone. The primary action of Recormon occurs in the bone marrow, where it binds to specific erythropoietin receptors on erythroid progenitor cells. This binding stimulates the proliferation and differentiation of these progenitor cells into mature red blood cells. By enhancing the production of red blood cells, Recormon effectively increases hemoglobin levels and improves oxygen delivery to tissues, thus alleviating symptoms associated with anemia. Additionally, it may have effects on iron metabolism and erythropoietin production feedback mechanisms, contributing to its therapeutic efficacy in various anemic conditions.
Indications and Uses of Recormon 5000i PREFILLED SYRINGE
- Management of anemia associated with chronic kidney disease.
- Treatment of anemia in patients undergoing chemotherapy for malignancies.
- Support of red blood cell production in patients with myelodysplastic syndromes.
- Increasing hemoglobin levels in patients with severe anemia due to various chronic diseases.
Side Effects of Recormon 5000i PREFILLED SYRINGE
- Headache
- Hypertension
- Nausea
- Fatigue
- Injection site reactions (e.g., pain, swelling)
- Thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism)
- Allergic reactions (e.g., rash, itching)
Storage and Handling
Store Recormon 5000i PREFILLED SYRINGE in a refrigerator between 2°C and 8°C. Do not freeze. Protect from light by keeping the syringe in its original packaging until use. Once removed from the refrigerator, it can be stored at room temperature for a limited time as per specific product guidelines.
Patient Advice and Precautions
Before initiating treatment, assess the patient’s iron levels and ensure adequate iron supplementation if necessary. Monitor hemoglobin levels regularly to avoid overtreatment, which can lead to cardiovascular complications. Patients should be advised to report any unusual symptoms, such as sudden headaches, vision changes, or chest pain. Injection site hygiene should be emphasized to minimize the risk of infection.